An Act to create 20.285 (1) (qh), 20.285 (1) (qi), 25.14 (1) (a) 14m., 25.17 (1) (jw), 25.51 and 36.25 (16) of the statutes; Relating to: creating a medicinal psilocybin treatment fund and a pilot program to study the effects of medicinal psilocybin treatment on patients with post-traumatic stress syndrome at the University of Wisconsin-Madison and making an appropriation. (FE)
| Date / House | Action | Journal |
|---|---|---|
| 12/6/2023 Asm. | Introduced by Representatives Gustafson, C. Anderson, Brooks, Edming, Murphy, Sapik, J. Anderson, Bare, Considine, Emerson, Jacobson, Joers, Ohnstad, Ortiz-Velez, Ratcliff, Shankland, Sinicki and Haywood; cosponsored by Senators James, Hesselbein, Agard, Larson, Roys and Spreitzer | |
| 12/6/2023 Asm. | Read first time and referred to Committee on Health, Aging and Long-Term Care | |
| 12/15/2023 Asm. | Representative Madison added as a coauthor | |
| 1/12/2024 Asm. | Fiscal estimate received | |
| 4/15/2024 Asm. | Failed to pass pursuant to Senate Joint Resolution 1 |
